RNF144A promotes ubiquitination degradation of YY1 [43], inhibits tumor cell proliferation and migration [44], and promotes ubiquitination degradation of HSPA2 [45], and these mechanisms lead to the inhibition of breast cancer by RNF144A. Here, YY1 is linked to breast carcinoma.